Daxor Corp. (DXR)

9.75 +0.35 (+3.70%) USD  |  NASDAQ  |  Jun 18, 16:00
9.46 -0.29 (-2.97%) After-Hours: 20:00
More

Daxor Research and Development Expense (Quarterly)

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for DXR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
December 31, 2011 0.7095M
September 30, 2011 0.6371M
June 30, 2011 0.6698M
March 31, 2011 0.6896M
December 31, 2010 0.7204M
September 30, 2010 0.6947M
June 30, 2010 0.7346M
March 31, 2010 0.892M
December 31, 2009 0.8911M
September 30, 2009 0.668M
June 30, 2009 0.6711M
March 31, 2009 0.595M
December 31, 2008 0.567M
September 30, 2008 0.6018M
June 30, 2008 0.6621M
March 31, 2008 0.6076M
December 31, 2007 0.5297M
September 30, 2007 0.6367M
June 30, 2007 0.6585M
March 31, 2007 0.7518M
December 31, 2006
September 30, 2006
June 30, 2006 0.00
March 31, 2006 0.00
December 31, 2005
Date Value
September 30, 2005 0.00
June 30, 2005
March 31, 2005 0.00
December 31, 2004 0.00
September 30, 2004 0.00
June 30, 2004 0.00
March 31, 2004 0.00
December 31, 2003 0.00
September 30, 2003 0.00
June 30, 2003 0.00
March 31, 2003 0.00
December 31, 2002 0.33M
September 30, 2002 0.00
June 30, 2002 0.00
March 31, 2002 0.00
December 31, 2001 0.3257M
September 30, 2001 0.00
June 30, 2001 0.00
March 31, 2001 0.00
December 31, 2000 0.2135M
September 30, 2000 0.00
June 30, 2000 0.00
March 31, 2000 0.00
December 31, 1999 0.015M
September 30, 1999 0.00

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
SkyAI, Inc. 0.1371M
Strive, Inc. (United States) --
Silvergate Capital Corp. --
Abbott Laboratories 767.00M
Acme United Corp. --